Vimarsana
Biggest News Aggregation in the World

John Glaspy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John Glaspy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Glaspy Today - Breaking & Trending Today

Aurobindo in-licenced chemotherapy induced neutropenia drug Ryzneuta gets USFDA nod, sends scrip soaring to 52-week high - Vimarsana News

Aurobindo in-licenced chemotherapy induced neutropenia drug Ryzneuta gets USFDA nod, sends scrip soaring to 52-week high

India Business News: Aurobindo Pharma has received approval from the US Food & Drug Administration (USFDA) for its long-acting Granulocyte colony-stimulating factor (G-CSF

UCLA in the News April 27, 2023 - Vimarsana News

UCLA in the News April 27, 2023

Highlights from MSNBC, Nature, CNN and others.

Source: ucla.edu
Fact check: No, bee stings are not a valid treatment for cancer - Vimarsana News

Fact check: No, bee stings are not a valid treatment for cancer

While studies have found bee venom was effective at killing cancer cells in a lab setting, such findings have not been replicated in humans.

Cancer Is a Man-Made Disease, Controversial Study Claims - Vimarsana News

Cancer Is a Man-Made Disease, Controversial Study Claims

Doctors and other scientists are not so sure.

TORL BioTherapeutics Launches with $158 Million Series B Financing to Advance Development of Novel Oncology Biologics - Vimarsana News

TORL BioTherapeutics Launches with $158 Million Series B Financing to Advance Development of Novel Oncology Biologics

Co-founded by acclaimed oncologist Dennis Slamon, M.D., Ph.D., of University of California at Los Angeles (UCLA) and entrepreneur and CEO David Licata, as well...